Immuno-proteomic analysis of human immune responses to experimental Neisseria meningitidis outer membrane vesicle vaccines identifies potential cross-reactive antigens
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Development of a group A meningococcal conjugate vaccine,MenAfriVacTMHuman Vaccines & Immunotherapeutics, 2012
- The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: Immunological, functional and structural characterization of the antigensVaccine, 2012
- Neisseria meningitidis: Biology, Microbiology, and Epidemiology2011
- Advances in the Development of Vaccines againstNeisseria meningitidisNew England Journal of Medicine, 2010
- Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidisVaccine, 2009
- Immunogenicity of a Tetravalent Meningococcal Glycoconjugate Vaccine in InfantsJAMA, 2008
- A universal vaccine for serogroup B meningococcusProceedings of the National Academy of Sciences, 2006
- MeNZB?: a safe and highly immunogenic tailor-made vaccine against the New Zealand serogroup B disease epidemic strainVaccine, 2005
- Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, BrazilThe Lancet, 1992
- ANTIGENIC SIMILARITIES BETWEEN BRAIN COMPONENTS AND BACTERIA CAUSING MENINGITISThe Lancet, 1983